Since PHLDA2 is a downstream target of EGFR/ErbB2, we analyzed PHLDA2, p-Erk and p-AKT expression in multiple lung cancer cell lines and a tissue microarray prepared with 117 well annotated primary lung cancer samples. The gene discussed is ERBB2; the disease is lung carcinoma.